Choices for treating the symptoms of benign prostatic hyperplasia (BPH) have never been so great and with the needs of BPH patients as varied as the treatments available, there is no “one-size-fits-all” solution to BPH management according to the review, “Recent advances in treatment for Benign Prostatic Hyperplasia,“ published in the journal F1000Research.
Researchers from Guy’s and St. Thomas NHS Trust, U.K., and Tauranga Hospital, New Zealand, who authored the review, said two themes frame the ongoing advances in BPH treatment: personalized medicine and what they call a medical technology revolution. While treatment options for BPH have traditionally been divided into medical and surgical, the authors argued that the line between the two is now rather blurred.